Chinese Brain Chip Project Aims to Implant into 13 Patients by Year’s End

A pioneering collaboration between the Chinese Institute for Brain Research (CIBR) and state-owned NeuCyber NeuroTech is set to accelerate human trials for a semi-invasive wireless brain chip, Beinao No.1. The joint effort announced on Monday aims to implant the device into 13 patients by the end of 2025, a bold move that could potentially challenge rivals like Elon Musk’s Neuralink.

According to Reuters, the Beijing-based team has already successfully implanted the chip into three patients over the past month, and plans to extend this to ten additional cases before year’s end. The chip is designed to assist patients with paralysis by enabling control of external devices, such as robotic arms, through neural signals. Videos released by state media demonstrate patients using the chip to operate robotic limbs and transmit thought commands to computer interfaces.

Luo Minmin, director of CIBR and chief scientist at NeuCyber, emphasized that pending regulatory approval, the program will evolve into formal clinical trials involving around 50 patients next year. The company also hinted at developing a wireless version of the chip, Beinao No.2, with human testing expected within the next 12 to 18 months.

This development underscores China’s commitment to advancing brain-computer interface technology and enhancing medical treatment for neurological conditions. As the global race for innovative neurotechnologies heats up, the success of this project could position China at the forefront of a field that promises to revolutionize how patients with severe motor impairments regain control of their lives.

Authorities and industry experts will be watching closely as NeuCyber and CIBR push forward with what could become a transformative breakthrough in neurotechnology.